APA

Vasquez A. E., Manzo R. A., Soto D. A., Barrientos M. J., Maldonado A. E., Mosqueira M., Avila A., Touma J., Bruce E., Harris P. R. & Venegas A. (20151222). Oral administration of recombinant Neisseria meningitidis PorA genetically fused to H. pylori HpaA antigen increases antibody levels in mouse serum, suggesting that PorA behaves as a putative adjuvant. : Human vaccines & immunotherapeutics.

Chicago

Vasquez Abel E, Manzo Ricardo A, Soto Daniel A, Barrientos Magaly J, Maldonado Aurora E, Mosqueira Macarena, Avila Anastasia, Touma Jorge, Bruce Elsa, Harris Paul R and Venegas Alejandro. 20151222. Oral administration of recombinant Neisseria meningitidis PorA genetically fused to H. pylori HpaA antigen increases antibody levels in mouse serum, suggesting that PorA behaves as a putative adjuvant. : Human vaccines & immunotherapeutics.

Harvard

Vasquez A. E., Manzo R. A., Soto D. A., Barrientos M. J., Maldonado A. E., Mosqueira M., Avila A., Touma J., Bruce E., Harris P. R. and Venegas A. (20151222). Oral administration of recombinant Neisseria meningitidis PorA genetically fused to H. pylori HpaA antigen increases antibody levels in mouse serum, suggesting that PorA behaves as a putative adjuvant. : Human vaccines & immunotherapeutics.

MLA

Vasquez Abel E, Manzo Ricardo A, Soto Daniel A, Barrientos Magaly J, Maldonado Aurora E, Mosqueira Macarena, Avila Anastasia, Touma Jorge, Bruce Elsa, Harris Paul R and Venegas Alejandro. Oral administration of recombinant Neisseria meningitidis PorA genetically fused to H. pylori HpaA antigen increases antibody levels in mouse serum, suggesting that PorA behaves as a putative adjuvant. : Human vaccines & immunotherapeutics. 20151222.